Toth Financial Advisory’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7
Closed -$1.69K 1010
2025
Q4
$1.69K Hold
7
﹤0.01% 729
2025
Q3
$1.92K Hold
7
﹤0.01% 697
2025
Q2
$1.81K Buy
+7
New +$1.67K ﹤0.01% 649
2023
Q3
Sell
-8
Closed -$1.75K 833
2023
Q2
$1.75K Sell
8
-7
-47% -$1.56K ﹤0.01% 650
2023
Q1
$3.29K Buy
15
+7
+88% +$1.52K ﹤0.01% 592
2022
Q4
$1.67K Hold
8
﹤0.01% 610
2022
Q3
$2K Buy
+8
New +$1.82K ﹤0.01% 650
2019
Q1
Sell
-40
Closed -$5K 451
2018
Q4
$5K Buy
+40
New +$4.29K ﹤0.01% 328

Other funds holding RMD

Toth Financial Advisory's RMD Position: Q1 2026 in Review

Toth Financial Advisory sold out of ResMed (RMD) in Q1 2026, closing a stake of 7 shares — an estimated $1.69K sold.

Toth Financial Advisory first reported a position in RMD in Q4 2018 and held it in 8 quarters. The position peaked at $5K in Q4 2018. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Toth Financial Advisory reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Toth Financial Advisory sold 7 ResMed shares in Q1 2026, an estimated $1.69K.
  • Toth Financial Advisory first reported a position in ResMed in Q4 2018 and held it in 8 quarters.
  • Toth Financial Advisory's ResMed position peaked at $5K in Q4 2018.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Toth Financial Advisory's 13F filing for Q1 2026, filed 16 Apr 2026.